Literature DB >> 25713131

Reply to Mackenzie: A comparison of Neu5Gc and α-gal xenoantigens.

Oliver M T Pearce1, Annie N Samraj1, Heinz Läubli1, Nissi M Varki2, Ajit Varki3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25713131      PMCID： PMC4378408          DOI： 10.1073/pnas.1500880112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  6 in total

1.  Implications of xenoglycan sensitivity for increased cancer risk.

Authors:  Kimberley J Mackenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-20       Impact factor: 11.205

2.  Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.

Authors:  Vered Padler-Karavani; Ajit Varki
Journal:  Xenotransplantation       Date:  2011 Jan-Feb       Impact factor: 3.907

3.  Cancer immunotherapy by intratumoral injection of α-gal glycolipids.

Authors:  Giles F Whalen; Mary Sullivan; Bilal Piperdi; Wahid Wasseff; Uri Galili
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

4.  The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Libby A Kelly; Shawna L Pochan; Lisa J Workman; Matthew S Perzanowski; Katherine M Kocan; John V Fahy; Lucy W Nganga; Eva Ronmark; Philip J Cooper; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2011-03-31       Impact factor: 10.793

5.  A red meat-derived glycan promotes inflammation and cancer progression.

Authors:  Annie N Samraj; Oliver M T Pearce; Heinz Läubli; Alyssa N Crittenden; Anne K Bergfeld; Kalyan Banda; Christopher J Gregg; Andrea E Bingman; Patrick Secrest; Sandra L Diaz; Nissi M Varki; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

Review 6.  Involvement of a non-human sialic Acid in human cancer.

Authors:  Annie N Samraj; Heinz Läubli; Nissi Varki; Ajit Varki
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.